Moreover, loss of SET7/9 increases breast cancer stem cell-like properties and enhances the EMT process, which is relevant to tumor resistance, suggesting that SET7/9 acts as a suppressor in breast cancer [126]. The gene discussed is SETD7; the disease is breast carcinoma.